Product Details

Gemcitabine for Injection BP is manufactured to strict BP-standard specifications for use in cancer chemotherapy. It is prescribed for the treatment of several solid tumor malignancies.

The injection combines:

• Gemcitabine — a nucleoside metabolic inhibitor (pyrimidine antimetabolite) that interferes with DNA synthesis, causing cell death in rapidly dividing cancer cells

Gemcitabine for Injection BP is indicated in the treatment of pancreatic, non-small cell lung, breast, ovarian, and bladder cancers. As a result, it is administered under close oncology supervision, typically in hospital infusion units and specialized cancer care centers.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Sterile lyophilized powder ensures stability before reconstitution
• Accurate potency per vial supports precise dosing in chemotherapy protocols
• Single Dose Vial format minimizes contamination risk
• Suitable for hospital pharmacies, oncology centers, and institutional supply